Revelation Biosciences, Inc. (REVBW) stock
REVBWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVB
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $16.05MP/E –Yield –
Revelation Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Revelation Biosciences's enterprise value was $1.36M on Oct 19, 2026, against $2.50M a year earlier. Over the last 5 years it ranged from -$10.40M to $102.72B, with a median of $3.61B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $1.36M | – |
| 2025 | Dec 31, 2025 | -$1.24M | -100.0% |
| 2024 | Dec 31, 2024 | $2.65B | -84.3% |
| 2023 | Dec 29, 2023 | $16.94B | -31.6% |
| 2022 | Dec 30, 2022 | $24.76B | -75.9% |
| 2021 | Dec 31, 2021 | $102.72B | -14.4% |
| 2020 | Dec 31, 2020 | $119.94B | – |